Cargando…

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis

INTRODUCTION: An impaired sense of smell has a remarkable impact on the quality of life. It is seen in a variety of neurodegenerative diseases such as Parkinson disease. In this study, we assessed the olfactory function in patients with Multiple Sclerosis (MS) by Sniff Magnitude Test (SMT). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almasi, Mostafa, Sahraian, Mohammad Ali, Haji Akhoundi, Fahimeh, Ezzati, Hamid Reza, Rohani, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Neuroscience Society 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114867/ https://www.ncbi.nlm.nih.gov/pubmed/33995931 http://dx.doi.org/10.32598/bcn.12.1.1368.1

Ejemplares similares

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Agenesis of the corpus callosum: a rare association with Ehlers-Danlos syndrome
por: AFRAKHTEH, Motahareh, et al.
Publicado: (2020)

Clinical and demographic factors affecting disease severity in patients with multiple sclerosis
por: Baghizadeh, Somayeh, et al.
Publicado: (2013)

Determinants of sexual dysfunction in women with multiple sclerosis
por: Mohammadi, Khadijeh, et al.
Publicado: (2013)

Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018
por: Almasi-Hashiani, Amir, et al.
Publicado: (2020)

Reply to Urbanization Theory for Growing Trend of Multiple Sclerosis Letter
por: DEHGHANI, Rouhullah, et al.
Publicado: (2017)

Palatal-Myoclonus as a Presentation of Hashimoto Encephalopathy: an interesting case report
por: Ghoreishi, Esmaeel, et al.
Publicado: (2013)

Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series
por: Amini, Payam, et al.
Publicado: (2021)

Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients from Iran
por: Aliomrani, Mehdi, et al.
Publicado: (2016)

The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry
por: DEHGHANI, Rouhullah, et al.
Publicado: (2015)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis
por: Harirchian, Mohammad Hossein, et al.
Publicado: (2014)

Raphe Nuclei Echogenicity and Diameter of Third Ventricle in Schizophrenia Measured by Transcranial Sonography
por: Mahdiar, Mahnoush, et al.
Publicado: (2023)

Epidemiology of multiple sclerosis in Qom: Demographic study in Iran
por: Rezaali, Saeed, et al.
Publicado: (2013)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Effect of an educational intervention based on the theory of planned behavior on improving medication adherence in patients with multiple sclerosis treated with injectable disease-modifying drugs: randomized controlled trial
por: Hamtaeigashti, Sara, et al.
Publicado: (2023)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports
por: Rastkar, Mohsen, et al.
Publicado: (2023)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models
por: Hosseinnataj, Abolfazl, et al.
Publicado: (2023)

Is it time to revise the classification of geographical distribution of multiple sclerosis?
por: Sahraian, Mohammad Ali, et al.
Publicado: (2012)

Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study
por: Mortazavi, Seyyed Hosein, et al.
Publicado: (2023)

Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran
por: Omrani, Mohammad Amin, et al.
Publicado: (2023)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
por: ESKANDARIEH, Sharareh, et al.
Publicado: (2017)

Islamic fasting and multiple sclerosis
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2014)

Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis
por: Moradi, Mahbubeh, et al.
Publicado: (2015)

Detection of Olfactory Dysfunction Using Olfactory Event Related Potentials in Young Patients with Multiple Sclerosis
por: Caminiti, Fabrizia, et al.
Publicado: (2014)

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
por: Salehi, Zahra, et al.
Publicado: (2022)

Tardive Akathisia with Asymmetric and Upper-body Presentation: Report of Two Cases and Literature Review
por: Shahidi, Gholamali, et al.
Publicado: (2018)

Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2022)

Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
por: Fattahi, Mohammad Reza, et al.
Publicado: (2022)

Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review
por: Maroufi, Hossein, et al.
Publicado: (2021)

Olfactory Dysfunction Reflects Disease Progression in Japanese Patients with Multiple Sclerosis
por: Okada, Kazumasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fnc3s92o0n5g7dtcgs967tbp9q